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Abstract
Skin carcinoma are among the most spread diagnosed tumours in the world. In this study, we investigated
the transfection of immortalized keratinocytes, used as an in vitro model for skin carcinoma, using antisense
technology and poly(2-(dimethylamino)ethyl methacrylate) (PDMAEMA)-based polymers, with original
architecture and functionalities. We tested PDMAEMA polymers with different structures: linear, with two
(DEA-PDMAEMA) or three (TEA-PDMAEMA) arms. The cytotoxicity of these polymers was assessed
over a wide range of apparent Mn (from 7600 to 64 600). At a N/P ratio of 7.38, cytotoxicity increases with
the Mn. Keratinocytes were transfected with a fluorescent oligonucleotide and then analyzed by flow cy-
tometry. For the three architectures tested, the percentage of transfected cells and abundance of internalized
oligonucleotide were closely related to the Mn of the polymer. Confocal microscopy and FACS analy-
ses showed a wide spread fine granular distribution of the oligonucleotide up to 3 days post-transfection.
Then, we assessed the silencing efficiency of the polymers, targeting GFP in GFP expressing keratinocytes.
The maximal silencing effect (±40%) was obtained using a DEA-PDMAEMA polymer (Mn = 30 300).
These results suggest that PDMAEMA-based polymers can be efficiently used to transfect immortalized
keratinocytes and, thus, open new perspectives in the therapy of skin carcinoma.
© Koninklijke Brill NV, Leiden, 2012
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1. Introduction
Skin cancers are among the most frequent diagnosed tumours in the world. Among
skin cancers, basal cell carcinoma are the most spread type [1]. Their formation
* To whom correspondence should be addressed. E-mail: nancy.vanoverstraeten@fundp.ac.be
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results from constitutional and/or inherited factors combined with environmental
factors. Skin carcinoma are usually treated by surgical excision [2], radiotherapy
[3–5], irradiation [6] or dynamic phototherapy [7]. However, these treatments are
painful and invasive. Skin carcinoma occurs in the epidermis made up by constantly
regenerating keratinocytes. Keratinocytes proliferate in the basal layer and then
move upwards, beginning a differentiation program in the suprabasal layers that cul-
minates at the surface into fully differentiated dead cells of the cornified layer [8].
In skin carcinoma, keratinocytes display an anarchistic proliferation characteristic
of the cancerous phenotype. Evidence suggests that there are also numerous tumour
suppressor genes involved in skin carcinogenesis [9–11]. Identification of activated
oncogenes and anti-apoptotic genes in cancer cells allows considering such genes
as targets in gene therapy. In this regard, antisense oligonucleotides (ASO) can be
used as a promising tool to efficiently silence a specific gene [12–16].
Recent advances in biotechnology have improved gene-delivery technology to
achieve safe and effective delivery of nucleic acids into cells for gene therapy. Be-
cause of their high efficiency, viral vectors are often used as gene delivery tools
[17–19]. However, safety, efficiency and producibility are serious concerns for clin-
ical applications [20]. To overcome these issues, non-viral vectors with enhanced
efficiency and safety are required.
Vectors such as cationic lipids and polymers have been widely studied [21–23].
Among those, cationic polymers, such as poly(L-lysine) (PLL) and polyethylen-
imine (PEI), are the best known [24]. PEI displays higher efficiency than PLL, but
with significant drawbacks including poor biocompatibility and non biodegradabil-
ity. Indeed, validation of these non-viral vectors in clinical trials requires minimal
interactions with biological components. The nucleic acid–vector complexes must
be small enough for renal elimination and inert towards blood constituents while
maintaining structure and efficiency of the nucleic acids trapped inside [25].
Most of the investigated polycations, such as PDADMAC or PDMAEMA, show
interesting transfection efficiencies [26–28]. The successful transfection of cells
with PDMAEMA polymers based polyplexes is assigned to their ability to destabi-
lize endosomes, as well as to dissociate easily from the DNA once delivered in the
cytosol [28]. The mechanism of internalization of these polyplexes has been shown
to proceed by both caveolae- and clathrin-dependent pathways [29].
Among the studies investigating new non-viral gene delivering tools a general
focus on the delivery of a plasmidic DNA is observable [30–32]. However, as we
aim for a gene silencing effect and not the expression of a foreign gene, we tried to
transfect an antisense oligonucleotide. Plasmidic DNA carriers are not always very
effective with oligonucleotides. Indeed, PLL can provide a poor efficiency, while
PEI displays a higher efficiency but with significant drawbacks, including poor bio-
compatibility and non-biodegradability, whereas the validation of these non-viral
vectors in clinical trials requires minimal interactions with biological components.
The formed cationic polymer/gene complexes, the so-called polyplexes, must be
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while maintaining structure and efficiency of the nucleic acids trapped inside [25].
Therefore, designing a polymer for specific oligonucleotide delivery is of high in-
terest and can find numerous applications in antisense therapy.
Here, we developed a new strategy for transfecting keratinocytes based on an-
tisense technology using original non-viral polymeric vectors. Polymeric vectors
present the advantage compared to cationic lipids, that they are much more versa-
tile, offering the possibilities of varying their composition, architecture and size in
a controlled way. We synthesized novel PDMAEMA-based architectures by ATRP
[33] and compared them with linear PDMAEMA polymers. We investigated the
efficiency of vectorisation of these polymers and their ability to ensure the effi-
ciency of an ASO to silence the green fluorescent protein (GFP) in immortalized
keratinocytes. We also analyzed the cellular uptake and intracellular trafficking of
the polyplexes. Our data show that a two-arm DEA-PDMAEMA with a Mn of about
30 000 was the most effective polymer.
2. Materials and Methods
2.1. Synthesis of PDMAEMA-Based (Co)Polymers
2.1.1. Materials
The mono-, di- and trifunctional initiators used in this study, i.e., ethyl 2-
bromoisobutyrate (EBiB), bis(α-bromoisobutyryl) N -methyl diethanolamine
(DEA), tris(α-bromoisobutyryl) triethanolamine (TEA), and their PDMAEMA
homo-polymers and palm-tree like co-polymers with α-methoxy, ω-metacrylate
poly(ethylene glycol) (MAPEG) (Figs 1 and 2; Table 1) were prepared by atom
transfer radical polymerization (ATRP) using copper(I) bromide (CuBr) ligated
with 1,1,4,7,10,10-hexamethyltriethylenetetramine (HMTETA, 97%; Aldrich) as
catalytic complex following a procedure recently reported [34].
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Figure 2. Schematic representation of palm-tree-like co-polymers. This figure is published in colour
in the online edition of this journal, which can be accessed via http://www.brill.nl/jbs
Table 1.
Characterization of the PDMAEMA-based (co)polymers
Code Initiator Mn (GPC) Mw/Mn Composition MAPEG (mol%)
L1 EBiB 7600 1.24 PDMAEMA 0
L2 EBiB 11 200 1.24 PDMAEMA 0
L3 EBiB 22 900 1.31 PDMAEMA 0
L4 EBiB 45 400 1.25 PDMAEMA 0
L5 EBiB 64 600 1.30 PDMAEMA 0
D2 DEA 10 100 1.52 DEA-PDMAEMA 0
D3 DEA 30 300 1.48 DEA-PDMAEMA 0
T3 TEA 31 600 1.44 TEA-PDMAEMA 0
T4 TEA 44 000 1.59 TEA-PDMAEMA 0
F4 EBiB 52 500 1.55 PDMAEMA-st-Hos 0
LP EBiB 24 200 1.50 PDMAEMA-b-PMAPEG 11
DP DEA 54 100 1.46 DEA-PDMAEMA-b-PMAPEG 12
TP TEA 61 500 1.52 TEA-PDMAEMA-b-PMAPEG 14
N ,N -dimethylamino-2-ethyl methacrylate (DMAEMA, from Aldrich, 98%) was
passed through a column of basic alumina to remove the stabilising agents and
stored under nitrogen atmosphere at −20°C. Ethyl 2-bromoisobutyrate (EBiB,
from Aldrich, 98%), 2-bromoisobutyryl-bromide (Br-iBuBr, Aldrich), HMTETA
and copper bromide (CuBr, 98%; Fluka) were used without further purification.
Benzothioxantheno-3,4-dicarboxylic anhydride (Hostasol-anh, Clariant) was used
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tyl)thioxantheno[2,1,9-dej]isoquinoline-1,3-dione (Hostasol-MA)) (Fig. 1) was
prepared from the precursor Hostasol-anh as described in the literature [35].
2.1.2. Method
To prepare PDMAEMA (e.g., L4 in Table 1), to a dried glass-tube was charged with
copper(I) bromide (CuBr) (17 mg, 0.12 mmol) and a magnetic stir bar. The tube was
closed with a three-way stopcock capped by a rubber septum and purged by three
repeated vacuum/nitrogen cycles. Separately, in a dried flask, HMTETA (22.4 mg,
0.115 mmol) and (6 ml, 35.6 mmol) were introduced and degassed of oxygen by
nitrogen sparging for 5 min before transferring the mixture into a glass tube placed
in a oil bath maintained at 30°C. Finally, the degassed initiator (EBiB) was added
to the tube with a previously degassed syringe. The polymerization was stopped
after 3 h by immersing the tube into a liquid nitrogen bath and the polymer was
selectively recovered by precipitation in a sevenfold volume excess of cold heptane
and dried until constant weight. Monomer conversion was 94%, determined by 1H-
NMR. The catalyst was removed by passing through a column of basic alumina via
THF or toluene solution. Homo-polymers PDMAEMA were prepared by the same
method controlling the ratio of the initiator. DEA and TEA homo-polymers were
prepared also by this method except the initiator were DEA and TEA instead of
EBiB.
For the co-polymerization with poly(ethylene glycol) α-methoxy, ω-methacry-
late (PMAPEG), after homo-polymerization of DMAEMA by ATRP as described,
previously nitrogen-sparged MAPEG/THF solution (1:1, v/v; 0.97 M) was added
with a degassed syringe into the glass reaction tube and co-polymerization was
conducted for 16 h under an atmosphere of nitrogen. The co-polymerization was
stopped by immersing the tube into a liquid nitrogen bath and the co-polymers
isolated by following the aforementioned purification procedure. LP (Table 1) was
recovered with 89% yield by this procedure.
2.1.3. Synthesis of Fluorescent PDMAEMA-st-Hostasol Co-Polymers for
Oligonucleotide Tracking
CuBr (3.8 mg, 0.026 mmol) and a magnetic bar were introduced in a dried glass-
tube. The tube was then closed with a three-way stopcock capped by a rubber
septum and purged by three repeated vacuum/nitrogen cycles. Separately, in a
dried flask, HMTETA (11.8 mg, 0.051 mmol), DMAEMA (1.4 ml, 11.5 mmol),
Hostasol-MA (52.0 mg, 0.115 mmol) and 2 ml THF (5 M) were introduced and
oxygen-degassed by bubbling with nitrogen for 5 min before tranferring the mix-
ture into the glass-tube placed in a oil bath maintained at 60°C. Finally, degassed
EBiB was added to the tube with a previously degassed syringe. The polymerisa-
tion was stopped after 16 h by immersing the tube into a liquid nitrogen bath and
the polymer was selectively recovered by precipitation from a sevenfold volume
excess of cold heptane and dried until constant weight. Monomer conversion was
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basic alumina via THF solution. After purification 0.94 mol% of the Hostasol-MA
was detected in the co-polymer (F4, Table 1) with UV-Vis spectroscopy.
2.1.4. Characterisation
The molar fraction of MAPEG in the co-polymers was determined by 1H-NMR
as previously reported [34] using a Bruker AMX-300 MHz spectrometer at room
temperature in CDCl3 enriched with 0.03% TMS. Gel-permeation chromatography
(GPC) was performed in THF + 2 wt% NEt3 at 35°C using a Polymer Laborato-
ries liquid chromatograph equipped with a PL-DG802 degasser, an isocratic HPLC
pump LC 1120 (flow rate 1 ml/min), a Marathon auto sampler (loop volume 200 µl,
solution concentration 1 mg/ml), a PL-DRI refractive index detector and three
columns: a PL gel 10 µm guard column and two PL gel Mixed-B 10 µm columns.
Poly(methyl methacrylate) standards were used for calibration. The amount of
Hostasol-MA in the co-polymer was measured by UV-Vis spectroscopy (ethanol,
25°C, Varian Cary 50 Scan) using the calibration graph presented as supporting
data.
2.2. Cells and Reagents
Immortalized human keratinocytes (IHK), ectopically expressing the catalytic sub-
unit of telomerase and characterized by inactivated p16INK-4A gene (N-hTERT
keratinocytes), were a kind gift of Prof. J. Rheinwald (Division of Dermatology,
Department of Medicine and Harvard Skin Disease Research Center). IHK cells
were grown at 37°C in a humidified atmosphere with 5% CO2 in Epilife Medium
(Cascade Biologics) supplemented with HKGS (Cascade Biologics). Cells were di-
luted (106 cells in a T75 flask) before reaching 80% confluence in order to maintain
exponential growth. In order to assess the silencing induced by ASO, an IHK cell
line (IHK-MAZ-GFP) stably expressing a destabilized form of GFP protein [36]
was created using a lentiviral approach. For this, the MAZ-GFP gene was ampli-
fied by PCR from the pMAZ-ODC vector (a generous gift from Prof. B. Epe) and
cloned into the pLenti6/V5-D-Topo vector (Invitrogen). The generation of the IHK-
MAZ-GFP cell line was performed using the 293FT (Invitrogen) cells following
manufacturer’s instruction. Blasticidin (20 µg/ml, Sigma-Aldrich) was used for the
selection of the positively transduced cells. Transduction efficiency was assessed
by visualisation of the GFP-positive cells by fluorescence microscopy. The addi-
tion of the proteasome inhibitor MG132 (Sigma-Aldrich) 4 h prior to observation
demonstrated that the turn-over of the GFP-MAZ protein is clearly dependent on
this degradation pathway.
2.3. Oligonucleotides and siRNAs
In order to assess the vectorisation efficiency of the polymers, fluorescent oligonu-
cleotides WA488 and WA647 were synthesized and purified by Eurogentec, by
grafting respectively Alexa 488 and Atto 647 to the following oligonucleotide:
5′-CCCTTGCTCACCAT-3′. An antisense oligonucleotide against the green fluo-
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tion of the oligonucleotides are W21∗: 5′-CTCCTCGCCCTTGCTCACCAT-3′ (nu-
cleotides 1–21). An oligonucleotide consisting of the scrambled sequence W21sc*
(5′-TCCATCGTTACCGTCCTCCCC-3′) was used as a negative control. In order
to normalise the results obtained by quantitative RT-PCR, we used a scrambled
oligonucleotide IL8sc* (sequence: 5′-GTGATTGAGAGTGGACCACACTGCGC
CAAC-3′). All the oligonucleotides used were phosphorothioate modified. We also
used siRNAs for highlighting the efficiency of the polymers used in this study.
The synthetic anti-GFP siRNAs used were designed as follows: sense, AACU
UCAGGGUCAGCUUGC; and antisense, GCAAGCUGACCCUGAAGUU (19-
mer) [37]. As control, we used the non-targeting siRNA from Eurogentec.
2.4. Preparation of Polyplexes and Transfection of IHK Cells
The day before transfection, cells were trypsinized and resuspended in medium be-
fore being transferred to 6-well plates at a density of 12 × 104 cells/well in a final
volume of 2 ml. The commercial agent used as reference for assessing the effi-
ciency of the transfection by polymers was the SuperFect (Qiagen) used following
the manufacturer’s instructions. SuperFect (6 µl) was added to 3 µl oligonucleotide
in 200 µl OptiMEM (Gibco). The mixture was left to stand for 10 min at room
temperature before being added onto the cells. SuperFect was shown to be the best
commercial agent for assessing the efficiency of vectorisation in the IHK cells,
but for demonstrating a silencing effect following the transfection of an antisense
oligonucleotide, Oligofectamine (Invitrogen) was the best performing commercial
agent. In both cases, we used optimal concentrations of mixtures according to the
manufacturer instructions to transfect the immortalised keratinocytes. The trans-
fection mixtures with Oligofectamine were prepared following the manufacturer’s
instructions. Briefly, 10 µl of a solution of oligonucleotides (20 µM) was diluted in
175 µl OptiMEM and 2 µl Oligofectamine was diluted in 15 µl OptiMEM. After
10 min of incubation at room temperature, the two solutions were gently mixed,
followed by a second incubation of 20 min at room temperature. The medium was
removed from the wells of the 6-well plate and 800 µl Epilife-HKGS medium was
added. The diluted complex was then overlayed and cells were incubated at 37°C
under a humidified atmosphere. After 4 h, the medium containing the mixture was
removed and fresh medium was added. Transfection experiments with polymers
were carried out as follows. After dilution of 4 µg oligonucleotide in 400 µl Opti-
MEM medium, the homo-polymer was gently added to the solution. After 30 min
of incubation, the diluted polyplex was overlayed on the cultured cells for 24 h.
Medium was changed after 4 h. In the case of a ternary complex, the co-polymer
was supplemented to the solution containing the homo-polymer and the oligonu-
cleotide after the 30 min incubation. Then the mixture was let for another 30 min at
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2.5. Checking of Complex Formation by Fluorescent Dye Exclusion Assay
For verifying the formation of a complex between our polymers and the 14-mer
oligonucleotide, we used the Quant-iT™ OliGreen® kit (Invitrogen), especially de-
signed to monitor the presence of an ssDNA in a complex solution. Briefly, we
formed complexes with different w/w ratios (1:1, 2:1, 3:1 or 10:1) in OptiMem
medium. After 30 min at room temperature, 800 µl TE medium was added. The
aqueous working solution of the Quant-iT™ OliGreen® reagent (1 ml) was added
to each sample. After incubation for 5 min in the dark at room temperature the
fluorescence of each sample was measured.
As recommended in the manufacturer’s instructions, a standard curve with the
14-mer oligonucleotide was made (Fig. 3).
2.6. Determination of Polymer Cytotoxicity (MTT)
Cell proliferation was measured one day post-transfection using MTT (Sigma) at
a final concentration of 2.5 mg/ml. Cells were incubated for 4 h with the MTT
solution, then the medium was removed and a lysis solution (30% SDS/N ,N -
dimethyl-formamide, 2:1 (v/v), pH 4.7 (80% acetic acid + 1 M HCl, 9:1)) was
added. After 1 h at 37°C, the developed colour of the formazan derivative was read
in a photometer at 570 nm using the lysis solution as blank. The optical density
(OD) of the blank was withdrawn from the OD of the different samples which was
reported to the control (non-transfected) cells.
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2.7. Determination of the Vectorisation Efficiency by Flow Cytometry
Cells were transfected with the fluorescent oligonucleotide WA488 as described
and were trypsinized and washed in PBS + 1% bovine serum albumin (BSA). Then
cells were resuspended in PBS + 1% BSA and analyzed for their fluorescence. Flow
cytometric data were acquired on a FACS Calibur flow cytometer (BD Biosciences)
and analyzed by the Cellquest software (BD Biosciences). Mean channel fluores-
cence values (MCFR) were calculated by reporting the mean fluorescence values
of the samples to the control. The percentage of transfected cells was calculated by
gating the fluorescent population compared to the control.
2.8. Intracellular Trafficking Study and Image Analysis
Cells were seeded on coverslips the day before transfection with the fluorescent
oligonucleotides. WA488 was used to monitor the persistence over time of the trans-
fected oligonucleotide, whereas WA647 was used for co-localisation experiments
allowing the discrimination of the fluorescence associated with the oligonucleotide
from the fluorescence associated with the polymer. At 24 h post-transfection, cells
were fixed for 10 min with 4% paraformaldehyde. After 3 washes in PBS, cov-
erslips were mounted in Mowiol (Kuraray) and processed for confocal microscopy
(Leica). Three specimens of each group were chosen and at least 4 randomly chosen
fields were analyzed.
2.9. RT-PCR Determination of GFP mRNA
At 24 h post-transfection with the W21* ASO (anti-GFP), total RNA was ex-
tracted with the RNAgents total RNA isolation system (Promega) and 500 ng
were used in reverse transcription using Superscript II reverse transcriptase (In-
vitrogen) according to the manufacturer’s instruction. Quantitative RT-PCR was
directly performed with the ice-cooled cDNA by monitoring the increase in fluores-
cence of incorporated SYBR Green dye (Applied Biosystems) with an ABI PRISM
7000 sequence detector system (Applied Biosystems). Specific primers for GFP
were designed using the Primer express software (Applied Biosystems): forward,
5′-CCTACGGCGTGCAGTGCT-3′; reverse, 5′-AGATGGTGCGCTCCTGGAC-
3′; and GAPDH: forward, 5′-ACCCACTCCTCCACCTTTGAC-3′; reverse, 5′-
ACCCACTCCTCCACCTTTGAC-3′. In order to improve the reproducibility of the
silencing experiments, IHK-GFPd cells were used between passages 5 and 15. We
also used a scrambled ASO sequence (IL8 scramble) to normalise the results ob-
tained by quantitative RT-PCR. Indeed, the comparison with a single housekeeping
gene can lead to relatively large errors in a significant proportion [38]. Therefore,
we decided to use another sequence to introduce another normalization factor for
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3. Results
3.1. Formation of Polyplexes Based on the Tested PDMAEMA Polymers
To ensure the formation of stable polyplexes with our PDMAEMA of different ar-
chitectures and a 14-mer oligonucleotide, we performed a fluorescent dye exclusion
assay with the Quant-iT™ OliGreen® kit. As the correlation coefficient of the stan-
dard curve was reliable, we analysed complexes formed with L3, D3, T3, LP or the
SuperFect with the described method (Fig. 4).
We observed a similar complexation between the linear, two- or three-arm
PDMAEMA polymers and the oligonucleotide for every ratio tested. For the w/w
ratio of 2:1, a poor difference between the tested PDMAEMA and the commercial
agent SuperFect was highlighted. Therefore, complexes between the PDMAEMA
of different architectures and an oligonucleotide can be formed at every w/w ratio
tested.
3.2. Cytotoxicity of the PDMAEMA Homo-Polymers
In the first series of experiments, we analyzed the cytotoxicity of the polyplexes
after transfection of the IHK cells with a 14-mer oligonucleotide using linear
PDMAEMA polymers. One day after seeding, the IHK cells were transfected using
linear PDMAEMA polymers within a broad range of average Mn at the optimal
N/P ratio of 7.38, corresponding to a ratio of 3:1 (w/w) (Fig. A.1 in the Appendix).
Figure 4. Checking of the presence of the oligonucleotide inside different complexes by dye exclusion
assay. Complexes of different polymer/oligonucleotide (w/w) ratio were produced and the presence of
the oligonucleotide in the complexes was assessed by dye exclusion. This figure is published in colour
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(a)
(b)
Figure 5. Cytotoxicity of the linear or branched PDMAEMA polymers. Cells were seeded
(15 × 103 cells/cm2) and were transfected the following day by linear PDMAEMA polymers (N/P =
7.38) of different Mn (a) or by DEA or TEA-initiated PDMAEMA polymers of Mn ≈ 26 000 (b).
MTT assay was performed 5 (grey columns) and 24 h (black columns) post-transfection (a) or 24 h
post-transfection (b). Data represent the mean ± SEM of 3 experiments; P < 0.01.
We also compared the cytotoxicity of the linear PDMAEMA versus branched DEA
or TEA-initiated PDMAEMA architectures at a Mn ≈ 26 000. Cytotoxicity was as-
sessed by the MTT test 5 and/or 24 h after transfection (Fig. 5a and b). In parallel,
we transfected IHK cells using SuperFect and assessed the cytotoxicity.
MTT assay revealed a cell viability for SuperFect-transfected cells of more than
80%. The MTT test revealed that the cytotoxicity of the polyplexes was closely
related to the Mn of the polymer used. Indeed, we noticed that the higher the Mn, the
higher the toxicity. Nevertheless, for a Mn  45 000, the viability of IHK cells was
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(a) (b)
Figure 6. Effect of the polymer Mn on the oligonucleotide vectorisation efficiency. Cells were
transfected with WA488 fluorescent oligonucleotide using different PDMAEMA polymers (N/P =
7.38), with the Mn ranging from 7600 to 64 699 (see Table 1 for details), without (a) or with (b)
PDMAEMA-b-PMAPEG co-polymers consecutively added. Cells were collected for flow cytometry
analysis 24 h post-transfection. This figure is published in colour in the online edition of this journal,
which can be accessed via http://www.brill.nl/jbs
3.3. Effect of the Polymer Mn on the Vectorisation Efficiency
We then tested several linear PDMAEMA polymers of different Mn for their ca-
pacity to vectorize IHK cells, i.e., their ability to internalize a genetic material. IHK
cells were transfected with the Alexa 488-labelled oligonucleotide (WA488), using
different PDMAEMA polymers with a N/P ratio of 7.38. At 24 h post-transfection,
we analyzed the efficiency of vectorisation by flow cytometry (Fig. 6a). For sake of
comparison, several commercial agents, i.e., FuGene, SuperFect, LipofectAmine
and Oligofectamine, all recognized for their high efficiency in transfection, were
also tested (data not shown). The best one proved to be SuperFect that was further
used as reference.
FACS analyses showed that the internalisation of the fluorescent oligonucleotide
is highly dependent on the Mn of the PDMAEMA polymer used for vectorisa-
tion. Indeed, the higher the Mn of the polymer, the better the incorporation of the
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ber of transfected cells observed. We also assessed different N/P ratios, 2.46 and
14.76. At the N/P ratio of 2.46, no cytotoxicity was observed for any of the lin-
ear polymers tested, but the vectorisation efficiency was low. On the contrary, with
N/P = 14.76 all polymers displayed a higher cytotoxicity, but an increased effi-
ciency (data not shown). As the addition of a P(DMAEMA-b-MAPEG) co-polymer
has been reported to improve the vectorisation efficiency and hemocompatibil-
ity of the polyplexes [39], we added a palm-tree-like co-polymer to pre-formed
PDMAEMA-oligonucleotide polyplexes and transfected IHK cells with the ternary
polyplexes (P(DMAEMA-b-MAPEG) + PDMAEMA + WA488). Internalisation
of the fluorescent oligonucleotide was used to assess the efficiency of vectorisation
(Fig. 6b). The formation of ternary polyplexes slightly improved the vectorisation
efficiency with low-Mn polymers while it did not affect the efficiency observed with
high-Mn polymers. However, the addition of a P(DMAEMA-b-MAPEG) polymer
increased the cytotoxicity of the polyplexes (Fig. A.1). Taken together, our results
on cytotoxicity and vectorisation efficiency, suggest that PDMAEMA polymers in
the range 22 900–45 400 seem the most suited for a compromise between accept-
able cytotoxicity and efficient vectorisation.
3.4. Effect of the Architecture on Vectorisation Efficiency
In order to improve the vectorisation efficiency, we used PDMAEMA based poly-
mers with different architectures. Two- (DEA-) or three- (TEA-) arm PDMAEMA
polymers were tested for transfecting IHK cells with the Alexa 488-labelled
oligonucleotide and the efficiency of vectorisation analyzed by flow cytometry
(Fig. 7a).
As for the linear PDMAEMA polymers, the internalisation of the fluorescent
oligonucleotide was closely related to the Mn of the branched PDMAEMA-based
polymers used for vectorisation. For polymers with a Mn of around 30 000, DEA-
initiated polymer D3 seemed to be slightly more efficient than the TEA-polymer
T3. Tertiary complexes (see Section 2) including P(DMAEMA-b-MAPEG) co-
polymers added in a second step to branched DEA- or TEA-PDMAEMA-based
polyplexes, did not seem to really improve the vectorisation (Fig. 7b), which is
in agreement with the data on linear PDMAEMA (Fig. 4b). Finally, we also tried
to find out if a direct grafting of MAPEG segments on linear, two- or three-arm
PDMAEMA polymers could have a beneficial effect on the vectorisation efficiency
(Fig. 7c). No architecture effect was noticed after vectorisation with the palm-
tree-like linear, two- or three-arms polymers as all polymers provided comparable
efficiencies.
3.5. Effects of the Polymer on the Persistence of Transfected Oligonucleotides
In order to assess the persistence of the oligonucleotides vectorized by PDMAEMA
or DEA-initiated PDMAEMA or TEA-initiated PDMAEMA polymers, we per-
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(a) (b)
(c)
Figure 7. Effect of polymer architecture on oligonucleotide vectorisation efficiency. Cells were trans-
fected with the WA488 fluorescent oligonucleotide using either (a) different DEA/TEA-PDMAEMA
polymers (N/P = 7.38) alone or (b) combined with PDMAEMA-b-PMAPEG polymers or
(c) DEA/TEA-PDMAEMA-b-PMAPEG polymers (see Table 1 for details). Cells were collected for
flow cytometry analysis 24 h post-transfection. This figure is published in colour in the online edition
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(a) (b)
(c)
Figure 8. Persistence of the oligonucleotide into the transfected cells. Cells were transfected
with the WA488 fluorescent oligonucleotide using either Superfect (SF), PDMAEMA (L3) or
DEA-PDMAEMA (D3) or TEA-PDMAEMA (T3) polymers (N/P = 7.38) or the PDMAEMA-b-
MAPEG co-polymer (LP) at (a) 24, (b) 48 and (c) 72 h post-transfection. Flow cytomery analysis of
cells transfected with SuperFect (—), L3 (—), D3 (· · ·), T3 (----) or LP (- - -). This figure is published
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The data suggest that most of the transfected oligonucleotides (60%) remained
inside the cells up to 3 days post-transfection, whereas cells transfected with Super-
Fect only retained 25% of the fluorescent oligonucleotides 2 days after transfection.
As previously, we observed a similar efficiency of the polymers L3, D3 and T3 at
24 h post-transfection. Over the following 24 h, this trend remained stable. How-
ever, we could observe a quicker decrease in efficiency of the polymers L3, D3 and
T3 compared to the polymer LP, especially after 72 h.
Flow cytometry analyses provide data on the percentage of cells efficiently trans-
fected and on the quantity of oligonucleotides internalized but do not provide
information about the distribution of oligonucleotides inside the cells. Therefore,
confocal microscopy analyses were performed on the cells transfected with the flu-
orescent WA488 oligonucleotide using linear, DEA- or TEA-initiated PDMAEMA
polymers after 1, 2 or 3 days to highlight the localisation and distribution of the
internalized polyplexes (Fig. 9).
After 24 h, the fluorescent oligonucleotide was detected inside the cells and was
distributed into many fluorescent dots scattered throughout the cytoplasm for most
cells. After 48 and 72 h, fluorescence was still observed inside the transfected im-
mortalized keratinocytes, confirming the flow cytometry observations. Altogether,
these data confirm that oligonucleotides remain in the cells up to 3 days after vec-
torisation with either PDMAEMA, DEA-PDMAEMA or TEA-PDMAEMA poly-
mers, with an improved persistence compared with SuperFect.
3.6. Intracellular Distribution of Fluorescent Polymers and Oligonucleotides
As biological activity is closely depending on the cellular uptake, intracellular sta-
bility of the polyplexes and bioavailability of the oligonucleotide, it is crucial to
monitor the uptake and trafficking. Therefore, we vectorized an Atto 647-labelled
oligonucleotide using a hostasol-labelled PDMAEMA polymer and analyzed the
distribution of their respective fluorescence by confocal microscopy 1, 2 and 3 days
after the transfection (Fig. 10).
At 24 h post-transfection, the polymer and the oligonucleotide partially co-
localized in the cell, but there are also clearly small aggregates of oligonucleotides
devoid of the polymer fluorescent signal, suggesting the disruption of some of the
polyplexes with the release the oligonucleotides. However, at 48 h post-transfection
aggregates of polymers and oligonucleotides were still observable. After 3 days,
confocal images confirmed that oligonucleotide associated fluorescence was still
present intracellularly, but less polyplexes were observed, which confirms the pre-
vious data on the persistence of oligonucleotides vectorized by PDMAEMA poly-
mers.
3.7. Effects of the Polymers on the Silencing Efficiency of Anti-GFP ASO
Up to now, we showed that PDMAEMA polymers with different architectures were
able to efficiently vectorise an ASO inside keratinocytes. Finally, it was of im-
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Figure 9. Analysis by confocal microscopy of cells transfected with the WA488 fluorescent oligonu-
cleotide using either PDMAEMA (L3), DEA-PDMAEMA (D3) or TEA-PDMAEMA (T3) polymers
(N/P = 7.38). The intracellular distribution of the transfected oligonucleotide was investigated 24, 48
or 72 h post-transfection. This figure is published in colour in the online edition of this journal, which
can be accessed via http://www.brill.nl/jbs
Therefore, we used a keratinocyte cell line expressing a destabilized GFP and we
transfected anti-GFP ASO with linear (L3), DEA-initiated (D3) or TEA-initiated
(T3) PDMAEMA polymers, with a comparable Mn and at a N/P ratio of 7.38.
Ternary complexes were not tested considering their high toxicity (Fig. A.1). At
24 h post-transfection, we analyzed the GFP mRNA abundance by quantitative RT-
PCR (Fig. 11a).
Although SuperFect proved to be highly efficient for vectorising the oligonu-
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(a) (b) (c)
Figure 10. Analysis by confocal microscopy of cells transfected with a fluorescent polymer (F4
(green) and an Atto 647-labelled oligonucleotide (WA647) (blue) after 24 (a), 48 (b) or 72 h (c).
Co-localization appears in turquoise. This figure is published in colour in the online edition of this
journal, which can be accessed via http://www.brill.nl/jbs
tamine (data not shown) which was used as reference in this part of the study. D3,
the DEA-initiated PDMAEMA polymer with a Mn of 30 300 gave the best results
with a reproducible GFP silencing of about 20–40%, which was comparable to the
silencing obtained with Oligofectamine. A limited silencing was observed when the
cells were transfected with the scrambled sequence (17%). No such silencing effect
was observed with the linear (L3) or TEA-PDMAEMA (T3) polymer.
In order to correlate the decrease in mRNA GFP level with the GFP expression
at the protein level, we measured the mean fluorescence of the transfected popula-
tions by flow cytometry. In order to compare the decrease of GFP protein abundance
after transfection using the different polymers, we reported the mean GFP fluores-
cence of IHK-GFPd cells transfected with the ASO GFP on the mean fluorescence
of IHK-GFPd cells transfected with a scrambled sequence. We confirmed that the
DEA-initiated PDMAEMA polymer D3 was able to ensure a silencing effect of
33%, whereas the PDMAEMA polymer L3 provided 13% of silencing and the
TEA-initiated polymer T3 showed only 2% of silencing. On the other hand, the
transfection by Oligofectamine achieved 11% of GFP silencing. These data con-
firmed that the D3 polymer was the best transfection agent for maintaining the
biologic activity of an antisense oligonucleotide in IHK cells (Table 2).
Finally, the D3 DEA-polymer was also used to vectorise siRNA, as shown in
Fig. 11b, with a reduction of about 50% of the GFP mRNA, confirming the versa-
tility of this polymer and its ability to vectorise short nucleic acid sequences.
4. Discussion
In this study, we investigated the transfection of immortalized keratinocytes, used
as an in vitro model for skin carcinoma. The aim of this work was to develop a
safe and efficient non-viral gene-delivery system focused on ASO. Therefore, vari-
ous PDMAEMA-based (co)polymers with different lengths and architectures were
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(a)
(b)
Figure 11. Relative reduction of GFP mRNA (%) in IHK-dGFP cells induced 24 h post-transfection
by (a) antisense (W21∗) targetting GFP or scrambled (W21SC3*) oligonucleotides using different
polymers (L3, D3 or T3). Data are given as the mean ± SEM (n = 3); ∗∗P = 0.01; ∗P = 0.05. This
experiment is representative of 4. (b) Cells were transfected with anti-GFP or non-targeting siRNA
using D3. Oligofectamine was used to compare the efficiency of the transfection by the PDMAEMA
polymers. This experiment is representative of 2. This figure is published in colour in the online edition
of this journal, which can be accessed via http://www.brill.nl/jbs
Table 2.
Mean fluorescence of IHK-GFPd cells transfected with antisense or scramble
oligonucleotide using linear (L3), two- (D3) or three-arm (T3) PDMAEMA polymer
L3 D3 T3 Oligofectamine
W21* 80.43 102.31 101.37 85.11
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ties with their efficiency not only to vectorise ASO, but also to ensure the silencing
effects of the vectorized ASO in immortalized keratinocytes. Together, our data
demonstrated the effectiveness of PDMAEMA-based polymers for transfecting ker-
atinocytes. First, we observed a significant influence of the molecular weight of the
polymer tested on the toxicity. Indeed, we showed that the cellular viability was
closely related to the Mn of the polymer used. As described previously [28, 40, 41],
we confirmed that a Mn around 30 000–40 000 ensures a good compromise between
low cytotoxicity and efficient vectorisation. We can assume that the molecular
weight of the polymer provides a good estimation of the size of the corresponding
complexes [42]. In the case of keratinocytes, the use of a PDMAEMA-b-PMAPEG
co-polymer, whatever the architecture, strongly increased the cytotoxicity. It was
shown that the primary mode of toxicity associated to polymers with high Mw is
membrane destabilisation [40].
An AFM study has previously highlighted that the Mw, the N/P ratio or the
cationic distribution of the condensing agent can strongly affect the dimension of
the condensate [43]. For instance, it was shown for PEI that low N/P ratios (N/P =
3) support low DNA condensation, whereas high N/P ratios (N/P >6) result in large
amounts of free PEI causing cytotoxicity [44]. Therefore, we investigated different
N/P ratios. In the case of the different PDMAEMA polymers studied here, it ap-
peared that an N/P ratio of 7.38 was the optimal ratio for conciliating efficiency of
vectorisation and low cytotoxicity. This N/P ratio corresponded to a weight ratio
of 3:1, which was shown to be appropriate for the stability of the complexes [45].
Using the PDMAEMA-b-PMAPEG co-polymer LP in addition to the pre-formed
polyplex, we observed that the N/P ratio was important but the weight ratio of the
polymer, the co-polymer and the oligonucleotide was even more important, as at a
N/P ratio of 7.4 only the weight ratio of 1.5:0.5:0.5 was not cytotoxic, whereas at
a ratio of 3:1:1 we observed 75% mortality (data not shown). However, the cellular
viability after transfection is highly dependent on the cell line studied. Indeed, the
IHK seemed highly sensitive to transfection, while SiHa cells, in immortalized ker-
atinocytes expressing the HPV virus, transfection by polymers with N/P ratios up
to 15 did not affect cell viability.
Analyses by confocal microscopy and flow cytometry revealed that in cells trans-
fected with the polymers, oligonucleotides remained inside the keratinocytes up to
three days after the transfection, which is significantly better than with SuperFect,
the commercial agent used for sake of comparison. Indeed, we observed by confocal
microscopy that 24 h after transfection polyplexes were disrupted in the cytoplasm
and oligonucleotides were still detectable after 3 days. This is in agreement with
the silencing experiments showing that the antisense oligonucleotide was effective
24 h after transfection.
Our data also clearly show that the best polymer for vectorisation was not neces-
sarily the best polymer for maintaining the biological activity of the transfected
oligonucleotide, in our case the silencing effect. As previously shown for plas-
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able to ensure an efficient vectorisation, the gene expression associated with the
cellular uptake is not necessarily as efficient. Therefore, even if the linear, two-
or three-arm PDMAEMA polymers provided comparable vectorisation properties,
the DEA-initiated PDMAEMA polymer D3 with a Mn of 30 300 was clearly the
most efficient in ensuring the silencing effect of the transfected anti-GFP oligonu-
cleotide, as evidenced both at the GFP mRNA and protein levels. This polymer was
also effective in vectorising functional siRNA.
Our results suggest that the best architecture of the PDMAEMA tested was the
DEA-initiated polymer D3 with a Mn of 30 300. This polymer had a rigid core with
two mobile arms. We assume that this architecture provided less steric obstruction
than the three-arm polymers. Indeed, in the TEA-initiated PDMAEMA polymer,
the rigid star in the core could form a large three dimensional net making release of
the trapped oligonucleotides more difficult. On the other hand, the linear polymer
was less efficient than the DEA polymer because it may form winds into a ball
and nodes that could impair the release of the oligonucleotide. Reports have also
shown that the stereochemistry of polymers used for transfection could affect the
biological properties of the vectorised material [47]. Thus, the two-arm polymer
structure seems to combine efficient binding to the oligonucleotide and endosomal
release.
5. Conclusion
In summary, we demonstrated that the two-arm PDMAEMA polymer of Mn =
30 000 can effectively transfect immortalized keratinocytes with antisense oligonu-
cleotides paving the way to novel skin carcinoma therapeutic applications.
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Appendix
Figure A.1. Cytotoxicity of the linear PDMAEMA polymer L3 or palm-tree PDMAEMA-b-
PMAPEG co-polymer LP. Cells were seeded (15 × 103 cells/cm2) and were transfected the following
day with homo- or co-polymer at different ratios (w/w) . SuperFect (SF) was used as control. MTT
assay was performed 24 h post-transfection. Data represent one experiment out of 3.
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